MWNA
ABBV icon

Marshall Wace North America’s AbbVie ABBV Stock Holding History

Marshall Wace North America’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$6.55M Buy
60,708
+46,459
+326% +$5.31M 0.03% 441
2021
Q2 		$1.6M Sell
14,249
-149,318
-91% -$16.8M 0.01% 869
2021
Q1 		$17.7M Sell
163,567
-288,542
-64% -$30.9M 0.07% 272
2020
Q4 		$48.4M Sell
452,109
-1,547,969
-77% -$149M 0.22% 122
2020
Q3 		$175M Sell
2,000,078
-1,298,961
-39% -$122M 1.12% 11
2020
Q2 		$324M Buy
3,299,039
+495,184
+18% +$43.6M 2.14% 4
2020
Q1 		$214M Buy
2,803,855
+764,094
+37% +$65.1M 1.62% 6
2019
Q4 		$181M Buy
2,039,761
+784,623
+63% +$65.1M 0.87% 28
2019
Q3 		$95M Buy
1,255,138
+523,132
+71% +$35.9M 0.54% 50
2019
Q2 		$53.2M Buy
732,006
+473,892
+184% +$37.2M 0.33% 82
2019
Q1 		$20.8M Buy
258,114
+26,928
+12% +$2.2M 0.15% 142
2018
Q4 		$21.3M Buy
231,186
+215,253
+1,351% +$18.9M 0.21% 101
2018
Q3 		$1.51M Buy
15,933
+3,533
+28% +$335K 0.01% 542
2018
Q2 		$1.15M Buy
12,400
+1,494
+14% +$146K 0.01% 899
2018
Q1 		$1.03M Buy
+10,906
New +$1.2M 0.01% 992
2017
Q3 		– Sell
-111,274
Closed -$8.12M – 1209
2017
Q2 		$8.12M Buy
111,274
+93,060
+511% +$6.26M 0.06% 372
2017
Q1 		$1.18M Buy
+18,214
New +$1.15M 0.01% 665
2013
Q4 		$1.37M Buy
+25,960
New +$1.28M 0.03% 345

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Marshall Wace North America's ABBV Position: Q3 2021 in Review

Marshall Wace North America increased its AbbVie (ABBV) stake by 326% in Q3 2021, buying an estimated $5.31M and bringing the position to 60,708 shares worth $6.55M. The position accounts for 0.03% of the portfolio, ranked #441.

Marshall Wace North America first reported a position in ABBV in Q4 2013 and has held it in 18 quarters since. The position peaked at $324M in Q2 2020. 2,656 funds tracked by Wall St. Rank hold ABBV as of Q3 2021.

  • Marshall Wace North America held 60,708 shares of AbbVie worth $6.55M as of Q3 2021.
  • Marshall Wace North America bought 46,459 AbbVie shares in Q3 2021, an estimated $5.31M.
  • AbbVie made up 0.03% of Marshall Wace North America's portfolio in Q3 2021, its #441 holding.
  • Marshall Wace North America first reported a position in AbbVie in Q4 2013 and has held it in 18 quarters since.
  • Marshall Wace North America's AbbVie position peaked at $324M in Q2 2020.
  • 2,656 funds tracked by Wall St. Rank held AbbVie as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.